KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Operating Margin (2017 - 2025)

Twist Bioscience (TWST) has disclosed Operating Margin for 6 consecutive years, with 5011200.0% as the latest value for Q3 2023.

  • On a quarterly basis, Operating Margin rose 501129924.0% to 5011200.0% in Q3 2023 year-over-year; TTM through Sep 2023 was 121.89%, a 656.0% decrease, with the full-year FY2024 number at 761486.21%, down 358169379.0% from a year prior.
  • Operating Margin was 5011200.0% for Q3 2023 at Twist Bioscience, up from 95.36% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 5011200.0% in Q3 2023 to a low of 325.27% in Q4 2019.
  • A 5-year average of 263615.23% and a median of 120.28% in 2021 define the central range for Operating Margin.
  • Peak YoY movement for Operating Margin: plummeted -12603bps in 2019, then surged 501129924bps in 2023.
  • Twist Bioscience's Operating Margin stood at 325.27% in 2019, then surged by 64bps to 116.45% in 2020, then decreased by -14bps to 133.13% in 2021, then soared by 38bps to 82.28% in 2022, then skyrocketed by 6090679bps to 5011200.0% in 2023.
  • Per Business Quant, the three most recent readings for TWST's Operating Margin are 5011200.0% (Q3 2023), 95.36% (Q2 2023), and 102.42% (Q1 2023).